南非限制艾滋病药物莱纳卡巴维尔在有限的试点诊所使用. South Africa restricts HIV drug lenacapavir to limited pilot clinics.

南非正在通过有限的,选择性的试点推出预防艾滋病药物lenacapavir而不是全国范围内的推广. South Africa is rolling out the HIV prevention drug lenacapavir through a limited, selective pilot rather than a nationwide rollout. 虽然政府邀请当地制造商生产仿制品, 但仅少数公共诊所可以使用. While the government invited local manufacturers to produce generic versions, access remains restricted to a small number of public clinics. 批评者认为这种方法优先考虑某些地区, 使数百万人处于脆弱状态, 并无法应对疫情的严重程度. Critics argue this approach, which prioritizes certain regions over others, leaves millions vulnerable and fails to match the scale of the epidemic.